Studying for the future ... breast cancer researcher Chris Ormandy largely works away from the bright lights that some high profile fund-raising causes attract. Photo: Jacky Ghossein
If the research never begins it will never end and neither will the cancer for some of its youngest victims.... Garvan Institute (click title to entry - thank you) research scientist is studying transcription factors - proteins which govern the behavior of genetic material - to determine how they might influence cells to develop as the aggressive ''triple negative'' form of breast cancer that affects mostly young women.
But the basic molecular understanding sought by Associate Professor Ormandy, group head of the institute's cancer research program, takes decades before changing treatment.
Advertisement: Story continues below
And it risks being overlooked in a culture of breast cancer fund-raising characterized by Pink Ribbon Day that may emphasize projects with a more immediate payoff....
If the research never begins it will never end and neither will the cancer for some of its youngest victims.... Garvan Institute (click title to entry - thank you) research scientist is studying transcription factors - proteins which govern the behavior of genetic material - to determine how they might influence cells to develop as the aggressive ''triple negative'' form of breast cancer that affects mostly young women.
But the basic molecular understanding sought by Associate Professor Ormandy, group head of the institute's cancer research program, takes decades before changing treatment.
Advertisement: Story continues below
And it risks being overlooked in a culture of breast cancer fund-raising characterized by Pink Ribbon Day that may emphasize projects with a more immediate payoff....
